| First-line immuno-oncology combination therapies in metastatic renal-cell carcinoma: results from the international metastatic renal-cell carcinoma database consortium S Dudani, J Graham, JC Wells, Z Bakouny, SK Pal, N Dizman, F Donskov, ... European urology 76 (6), 861-867, 2019 | 79 | 2019 |
| Heat shock protein 90 (hsp90) expression and breast cancer F Zagouri, E Bournakis, K Koutsoukos, CA Papadimitriou Pharmaceuticals 5 (9), 1008-1020, 2012 | 78 | 2012 |
| Trastuzumab deruxtecan (DS-8201a): the latest research and advances in breast cancer A Andrikopoulou, E Zografos, M Liontos, K Koutsoukos, MA Dimopoulos, ... Clinical breast cancer 21 (3), e212-e219, 2021 | 52 | 2021 |
| How we treat endocrine complications of immune checkpoint inhibitors SA Paschou, K Stefanaki, T Psaltopoulou, M Liontos, K Koutsoukos, ... ESMO open 6 (1), 100011, 2021 | 44 | 2021 |
| Management of uterine sarcomas and prognostic indicators: real world data from a single-institution A Kyriazoglou, M Liontos, DC Ziogas, F Zagouri, K Koutsoukos, G Tsironis, ... BMC cancer 18, 1-8, 2018 | 39 | 2018 |
| Synchronous versus metachronous metastatic disease: impact of time to metastasis on patient outcome—results from the International Metastatic Renal Cell Carcinoma Database … F Donskov, W Xie, A Overby, JC Wells, AP Fraccon, CS Sacco, C Porta, ... European urology oncology 3 (4), 530-539, 2020 | 38 | 2020 |
| Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors E Terpos, F Zagouri, M Liontos, AD Sklirou, K Koutsoukos, C Markellos, ... Journal of Hematology & Oncology 14, 1-4, 2021 | 36 | 2021 |
| Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma M Dimou, MK Angelopoulou, GA Pangalis, G Georgiou, C Kalpadakis, ... Leukemia & lymphoma 53 (8), 1481-1487, 2012 | 35 | 2012 |
| The emerging role of BET inhibitors in breast cancer A Andrikopoulou, M Liontos, K Koutsoukos, MA Dimopoulos, F Zagouri The Breast 53, 152-163, 2020 | 32 | 2020 |
| The development of an angiogenic protein “signature” in ovarian cancer ascites as a tool for biologic and prognostic profiling SP Trachana, E Pilalis, NG Gavalas, K Tzannis, O Papadodima, M Liontos, ... PLoS One 11 (6), e0156403, 2016 | 29 | 2016 |
| Clinical perspectives of BET inhibition in ovarian cancer A Andrikopoulou, M Liontos, K Koutsoukos, MA Dimopoulos, F Zagouri Cellular Oncology 44, 237-249, 2021 | 28 | 2021 |
| Outcome of men with relapses after adjuvant bleomycin, etoposide, and cisplatin for clinical stage I nonseminoma S Fischer, T Tandstad, G Cohn-Cedermark, C Thibault, B Vincenzi, ... Journal of Clinical Oncology 38 (12), 1322-1331, 2020 | 26 | 2020 |
| Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer … M Liontos, EA Trigka, P Korkolopoulou, K Tzannis, G Lainakis, ... World journal of urology 35, 411-419, 2017 | 22 | 2017 |
| MicroRNAs as potential predictors of response to CDK4/6 inhibitor treatment A Andrikopoulou, A Shalit, E Zografos, K Koutsoukos, AM Korakiti, ... Cancers 13 (16), 4114, 2021 | 17 | 2021 |
| Breakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibling anymore? G Tsironis, DC Ziogas, A Kyriazoglou, M Lykka, K Koutsoukos, A Bamias, ... Annals of Translational Medicine 6 (8), 2018 | 16 | 2018 |
| SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors F Zagouri, E Terpos, O Fiste, M Liontos, A Briasoulis, I Katsiana, E Skafida, ... The Breast 60, 58-61, 2021 | 15 | 2021 |
| The emerging role of immunotherapy in intrahepatic cholangiocarcinoma O Fiste, I Ntanasis-Stathopoulos, M Gavriatopoulou, M Liontos, ... Vaccines 9 (5), 422, 2021 | 15 | 2021 |
| Oncological patients with endocrine complications after immunotherapy with checkpoint inhibitors present longer progression-free and overall survival SA Paschou, M Liontos, E Eleftherakis-Papaiakovou, K Stefanaki, ... Frontiers in Oncology 12, 847917, 2022 | 14 | 2022 |
| Novel therapies for advanced squamous cell carcinoma of the lung K Koutsoukos, G Mountzios Future Oncology 12 (5), 659-667, 2016 | 14 | 2016 |
| Immunological response to COVID-19 vaccination in ovarian cancer patients receiving PARP inhibitors M Liontos, E Terpos, C Markellos, F Zagouri, A Briasoulis, I Katsiana, ... Vaccines 9 (10), 1148, 2021 | 13 | 2021 |
